141 related articles for article (PubMed ID: 18815214)
1. Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib.
Hasinoff BB; Patel D; O'Hara KA
Mol Pharmacol; 2008 Dec; 74(6):1722-8. PubMed ID: 18815214
[TBL] [Abstract][Full Text] [Related]
2. Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations.
Cohen JD; Babiarz JE; Abrams RM; Guo L; Kameoka S; Chiao E; Taunton J; Kolaja KL
Toxicol Appl Pharmacol; 2011 Nov; 257(1):74-83. PubMed ID: 21906609
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of myocyte cytotoxicity induced by the multikinase inhibitor sorafenib.
Hasinoff BB; Patel D
Cardiovasc Toxicol; 2010 Mar; 10(1):1-8. PubMed ID: 19915982
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase.
Kerkela R; Woulfe KC; Durand JB; Vagnozzi R; Kramer D; Chu TF; Beahm C; Chen MH; Force T
Clin Transl Sci; 2009 Feb; 2(1):15-25. PubMed ID: 20376335
[TBL] [Abstract][Full Text] [Related]
6. Carnitine Supplementation Attenuates Sunitinib-Induced Inhibition of AMP-Activated Protein Kinase Downstream Signals in Cardiac Tissues.
Sayed-Ahmed MM; Alrufaiq BI; Alrikabi A; Abdullah ML; Hafez MM; Al-Shabanah OA
Cardiovasc Toxicol; 2019 Aug; 19(4):344-356. PubMed ID: 30644033
[TBL] [Abstract][Full Text] [Related]
7. Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition.
Stuhlmiller TJ; Zawistowski JS; Chen X; Sciaky N; Angus SP; Hicks ST; Parry TL; Huang W; Beak JY; Willis MS; Johnson GL; Jensen BC
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051215
[TBL] [Abstract][Full Text] [Related]
8. The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro.
Hasinoff BB; Patel D
Toxicol Appl Pharmacol; 2010 Dec; 249(2):132-9. PubMed ID: 20832415
[TBL] [Abstract][Full Text] [Related]
9. Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3.
An D; Kewalramani G; Chan JK; Qi D; Ghosh S; Pulinilkunnil T; Abrahani A; Innis SM; Rodrigues B
Diabetologia; 2006 Sep; 49(9):2174-84. PubMed ID: 16868748
[TBL] [Abstract][Full Text] [Related]
10. Involvement of mitogen activated kinase kinase 7 intracellular signalling pathway in Sunitinib-induced cardiotoxicity.
Cooper SL; Sandhu H; Hussain A; Mee C; Maddock H
Toxicology; 2018 Feb; 394():72-83. PubMed ID: 29248607
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the Cardiac Myocyte-Damaging Effects of Dasatinib.
Hasinoff BB; Patel D
Cardiovasc Toxicol; 2020 Aug; 20(4):380-389. PubMed ID: 32124237
[TBL] [Abstract][Full Text] [Related]
12. Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors.
Patyna S; Arrigoni C; Terron A; Kim TW; Heward JK; Vonderfecht SL; Denlinger R; Turnquist SE; Evering W
Toxicol Pathol; 2008 Dec; 36(7):905-16. PubMed ID: 18981453
[TBL] [Abstract][Full Text] [Related]
13. Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells.
Will Y; Dykens JA; Nadanaciva S; Hirakawa B; Jamieson J; Marroquin LD; Hynes J; Patyna S; Jessen BA
Toxicol Sci; 2008 Nov; 106(1):153-61. PubMed ID: 18664550
[TBL] [Abstract][Full Text] [Related]
14. Effect of phosphorylation by AMP-activated protein kinase on palmitoyl-CoA inhibition of skeletal muscle acetyl-CoA carboxylase.
Rubink DS; Winder WW
J Appl Physiol (1985); 2005 Apr; 98(4):1221-7. PubMed ID: 15579580
[TBL] [Abstract][Full Text] [Related]
15. Oestrogen enhances cardiotoxicity induced by Sunitinib by regulation of drug transport and metabolism.
Harvey PA; Leinwand LA
Cardiovasc Res; 2015 Jul; 107(1):66-77. PubMed ID: 26009590
[TBL] [Abstract][Full Text] [Related]
16. Role of the atypical protein kinase Czeta in regulation of 5'-AMP-activated protein kinase in cardiac and skeletal muscle.
Ussher JR; Jaswal JS; Wagg CS; Armstrong HE; Lopaschuk DG; Keung W; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E349-57. PubMed ID: 19625676
[TBL] [Abstract][Full Text] [Related]
17. Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration.
Zhang L; He H; Balschi JA
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H457-66. PubMed ID: 17369473
[TBL] [Abstract][Full Text] [Related]
18. Metformin Protects Against Sunitinib-induced Cardiotoxicity: Investigating the Role of AMPK.
Kuburas R; Gharanei M; Haussmann I; Maddock H; Sandhu H
J Cardiovasc Pharmacol; 2022 Jun; 79(6):799-807. PubMed ID: 35266920
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake.
Stevanovic D; Janjetovic K; Misirkic M; Vucicevic L; Sumarac-Dumanovic M; Micic D; Starcevic V; Trajkovic V
Neuroendocrinology; 2012; 96(1):24-31. PubMed ID: 22343549
[TBL] [Abstract][Full Text] [Related]
20. Autophagy plays an important role in sunitinib-mediated cell death in H9c2 cardiac muscle cells.
Zhao Y; Xue T; Yang X; Zhu H; Ding X; Lou L; Lu W; Yang B; He Q
Toxicol Appl Pharmacol; 2010 Oct; 248(1):20-7. PubMed ID: 20637791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
